Annalisa Jenkins
Direktor/Vorstandsmitglied bei AFFIMED N.V.
Vermögen: 194 932 $ am 30.06.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Punit Dhillon | M | 44 | 6 Jahre | |
Adam Hill | M | 44 |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | 6 Jahre |
Thomas O. Hecht | M | 73 |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom.
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | 17 Jahre |
Ron Kirschner | M | - | 4 Jahre | |
Matthew David Robson | M | 55 |
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | 12 Jahre |
Mary Thistle | F | 64 |
Cocoon Biotech, Inc.
Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | 3 Jahre |
Rajarshi Banerjee | M | 47 |
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | 12 Jahre |
Geoffrey Neil Hamilton-Fairley | M | 63 |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | 19 Jahre |
George Goldsmith | M | 68 |
COMPASS Pathfinder Holdings Ltd.
COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | 8 Jahre |
David Norton | M | 72 |
COMPASS Pathfinder Holdings Ltd.
COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | 6 Jahre |
Ekaterina Malievskaia | M | 57 |
COMPASS Pathfinder Holdings Ltd.
COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | 8 Jahre |
Adolf Hoess | M | 62 |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | 14 Jahre |
Harry Welten | M | 59 |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | 4 Jahre |
Vishal Kumar Gulati | M | - |
British Heart Foundation
| 6 Jahre |
Ulrich Grau | M | 75 |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | 9 Jahre |
Ailis Tweed-Kent | M | - |
Cocoon Biotech, Inc.
Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | 11 Jahre |
Bernhard R. M. Ehmer | M | 69 |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | 8 Jahre |
Mike Brady | M | 79 |
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom.
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | 12 Jahre |
Denise Scots-Knight | M | 64 | 9 Jahre | |
Andrew Unitt | M | 66 |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | 9 Jahre |
Charles Sermon | M | 55 | 9 Jahre | |
Jonathan Symonds | M | 66 |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | 10 Jahre |
Ferdinand Verdonck | M | 81 |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | 10 Jahre |
Stefan Karl Neubauer | M | - |
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | 12 Jahre |
Bruce Keogh | M | 69 | 6 Jahre | |
Michael Wyzga | M | 69 | 5 Jahre | |
Mary-Rose Hughes | F | - | 4 Jahre | |
Ellyn Shook | F | 60 |
Coqual
Coqual Miscellaneous Commercial ServicesCommercial Services Coqual, formerly known as the Center for Talent Innovation, is a nonprofit think tank that helps leaders create diverse, equitable, and inclusive workplaces. The non-profit company is based in New York, NY, and was founded by Sylvia Ann Hewlett. The company focuses on conducting cutting-edge research and providing advisory services on various identities, including gender, race, ethnicity, disability, veteran status, and LGBTQ. Coqual was founded in 2004 and offers in-depth research, thought leadership, and data-driven solutions to address bias and barriers to inclusion for underrepresented populations in the workplace. Lanaya Irvin has been the CEO of the company since 2020.
Women's Forum, Inc.
Women's Forum, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leadership Foundations, Women's Forum, Inc. is a non-profit community for women leaders of diverse achievement. The company is based in New York, NY. | - |
Meinhard Folkert Schmidt | M | 64 |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | 9 Jahre |
Robert Bazemore | M | 56 | 8 Jahre | |
Keith Ward | M | 54 | 3 Jahre | |
Marie Wikström Lindholm | M | - | 7 Jahre | |
Atique Mirza | M | - |
Ryse Asset Management LLP
Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | - |
Teresa Young | M | 57 |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | 9 Jahre |
Kabir Kumar Nath | M | 59 | 2 Jahre | |
Matti Leppälä | M | - |
The European Commission
| - |
Constanze Ulmer-Eilfort | M | 62 | 1 Jahre | |
Mary Beth Sandin | F | - | - | |
Lanaya Irvin | F | - |
Coqual
Coqual Miscellaneous Commercial ServicesCommercial Services Coqual, formerly known as the Center for Talent Innovation, is a nonprofit think tank that helps leaders create diverse, equitable, and inclusive workplaces. The non-profit company is based in New York, NY, and was founded by Sylvia Ann Hewlett. The company focuses on conducting cutting-edge research and providing advisory services on various identities, including gender, race, ethnicity, disability, veteran status, and LGBTQ. Coqual was founded in 2004 and offers in-depth research, thought leadership, and data-driven solutions to address bias and barriers to inclusion for underrepresented populations in the workplace. Lanaya Irvin has been the CEO of the company since 2020. | 4 Jahre |
Deborah Charych | M | - | 1 Jahre | |
Florian Brand | M | 37 |
COMPASS Pathfinder Holdings Ltd.
COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | 2 Jahre |
Karah Parschauer | F | 46 | 7 Jahre | |
Kevin Jong Lin Lim | M | 48 |
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | 4 Jahre |
Onaiza Cadoret-Manier | F | 60 | 4 Jahre | |
Graham Colbert | M | - |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | - |
Wolfgang Fischer | M | 60 |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | 7 Jahre |
Todd Krueger | M | - |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | - |
Jamie Heywood | M | - |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | - |
Mathieu Simon | M | 68 |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | 6 Jahre |
David Gill | M | 69 |
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | 3 Jahre |
Uta Kemmerich-Keil | F | 58 | 3 Jahre | |
Ann Sarnoff | F | 62 |
Women's Forum, Inc.
Women's Forum, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leadership Foundations, Women's Forum, Inc. is a non-profit community for women leaders of diverse achievement. The company is based in New York, NY. | - |
Margaret Dalesandro | M | 77 | 4 Jahre | |
William Bertrand | M | 59 | 9 Jahre | |
Linda McGoldrick | M | 69 | 4 Jahre | |
Praveen Tyle | M | 64 | 3 Jahre | |
Robert McQuade | M | 67 | 4 Jahre | |
David Lemus | M | 61 | 6 Jahre | |
Deepa Pakianathan | M | 59 | 5 Jahre | |
John H. Salmon | M | 79 |
British Heart Foundation
| - |
John P. Richard | M | 66 | 9 Jahre | |
Douglas P. Rosefsky | M | - |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | 6 Jahre |
Jill Granoff | F | 61 |
Women's Forum, Inc.
Women's Forum, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leadership Foundations, Women's Forum, Inc. is a non-profit community for women leaders of diverse achievement. The company is based in New York, NY. | - |
John Bell | M | 72 |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | - |
Michael Rosenblatt | M | 76 |
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | - |
Richard N. Merkin | M | - |
FasterCures
| - |
Andreas Harstrick | M | 63 | 4 Jahre | |
Michael A. Byrne | M | - |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | 24 Jahre |
Arthur P. DeCillis | M | 68 |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada.
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | 9 Jahre |
Eliot Forster | M | 58 |
MedCity Ltd.
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | 9 Jahre |
Wayne Riley | M | 64 | 3 Jahre | |
Anders Olof Adolf Ekblom | M | 70 | 9 Jahre | |
Chun Hou Tan | M | 48 |
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | 7 Jahre |
Dido Harding | F | 56 |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | - |
Martin Gouldstone | M | 57 | 1 Jahre | |
Sally Christina Waterman | M | - | 1 Jahre | |
Thomas Hawes | M | 48 |
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom.
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | 4 Jahre |
Andrea Murray | M | - |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | 20 Jahre |
Thomas Lönngren | M | 73 | 5 Jahre | |
Paul Herbert Chew | M | 72 |
PhESi LLC
PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | 6 Jahre |
Richard Scott | M | - |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | 9 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Erik Ostrowski | M | 51 | 5 Jahre | |
Andrew Millet | M | 57 |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | - |
Joanne Hackett | M | 45 | - | |
Mark E. Kaufmann | M | 56 | 9 Jahre | |
Geoff MacKay | M | 57 | 8 Jahre | |
Rishi Gupta | M | 46 | - | |
Daniel O'Connor | M | 59 | 4 Jahre | |
Peter John Fellner | M | 80 | 7 Jahre | |
Kevin Boyle | M | 50 |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | 3 Jahre |
Peter G. Schultz | M | 67 | 8 Jahre | |
Gregg Stephen Sando | M | - |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | 12 Jahre |
Michael Dybbs | M | 49 | 2 Jahre | |
Jean Franchi | F | 57 | 2 Jahre | |
Lars Christian Wilde | M | - | 5 Jahre | |
Erick Lucera | M | 56 |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | 1 Jahre |
Kim Warren | M | - | 5 Jahre | |
Stéphane Henchoz | M | 56 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | 22 Jahre |
Andrea Park | F | 52 | - | |
Wendel D. Barr | M | 62 |
Vium, Inc.
Vium, Inc. Information Technology ServicesTechnology Services Vium, Inc. provides technology for preclinical drug discovery services. It offers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. The company was founded by Timothy L. Robertson and Jonathan Betts-Lacroix in 2013 and is headquartered in San Mateo, CA. | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigtes Königreich | 51 | 51,00% |
Vereinigte Staaten | 33 | 33,00% |
Deutschland | 12 | 12,00% |
Kanada | 3 | 3,00% |
Schweiz | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Annalisa Jenkins
- Persönliches Netzwerk